Highbridge Capital Management LLC has recently announced that it has increased stake in BioPlus Acquisition Corp. (NASDAQ:BIOS) by 46.66%. After grabbing 2.07 million shares, the institutional investor is now in possession of 0.66 million shares of the Financial Company. The new investment brought the stake of investor firm to 8.79% having worth around $21.08 million. Moreover, Cantor Fitzgerald Securities increased its share by 0.4 million to have a control over 1.25 million shares. And Millennium Management LLC raised its holdings to 6159.0 shares by acquiring 1.13 million shares or 4.80% of the stake.
BioPlus Acquisition Corp. (BIOS) concluded trading on 01/11/23 at a closing price of $10.29, with 1.05 million shares of worth about $10.8 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 4.36% during that period and on Wednesday the price saw a gain of about 0.10%. Currently the company’s common shares owned by public are about 29.31M shares, out of which, 16.93M shares are available for trading.
Will You Miss Out On This Growth Stock Boom?
A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.
And this is just one of our
5 Best Growth Stocks To Own For 2023.
Sponsored
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 0 times over the past 12 months. They bought 0 shares in 0 of the transactions. In 0 selling transactions, insiders dumped 0 shares.
Calamos Market Neutral Income Fun, First Trust Merger Arbitrage Fund, and Janus Henderson Strategic Invt. F are the top 3 mutual funds which are holding stakes in BioPlus Acquisition Corp. Calamos Market Neutral Income Fun is currently holding 1.0 million shares of worth totaling $10.18 million. The company recently came buying 1.0 million shares which brought its stake up to 4.24% of the company’s outstanding shares. First Trust Merger Arbitrage Fund bought 50000.0 shares, after which its hold over company’s outstanding shares expand to 0.59%, leaving 0.14 million shares with the mutual fund that have a worth of about $1.43 million. Janus Henderson Strategic Invt. F, after buying 0.12 million shares, have now control over 0.49% of the stake in the company. It holds 0.0 shares of worth $1.18 million.
BioPlus Acquisition Corp. (NASDAQ: BIOS) started trading at $10.285, above $0.01 from concluding price of the previous day. However, the stock later moved at a day high price of 10.30, or with a gain of 0.10%. Stock saw a price change of 0.19% in past 5 days and over the past one month there was a price change of 1.38%. Over the period of past 52 weeks, stock dropped to lowest price of $9.78 but also hit the highest price of $10.28 during that period. The average intraday trading volume for BioPlus Acquisition Corp. shares is 64.84K. The stock is currently trading 0.72% above its 20-day simple moving average (SMA20), while that difference is up 1.49% for SMA50 and it goes to 2.81% higher than SMA200.
Highbridge Capital Management LLC acquired 2.07 million shares of BioPlus Acquisition Corp. having value of about $21.08 million. Data submitted at the U.S SEC by Highbridge Capital Management LLC revealed that the firm now holds 0.66 million shares in the company valued at close to $6780533.76, or have control over 46.66% stake in the company. BioPlus Acquisition Corp. (NASDAQ: BIOS) currently have 29.31M outstanding shares and institutions hold larger chunk of about 85.80% of that. Holding of mutual funds in the company is about 5.89% while other institutional holders and individual stake holders have control over 79.22% and 1.61% of the stake respectively.
The stock has a current market capitalization of $301.60M. PE ratio of stock for trailing 12 months is 1143.33, while it has posted earnings per share of $0.01 in the same period. Its PEG reads 114.33 and has Quick Ratio of 2.20 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for BIOS, volatility over the week remained 0.06% while standing at 0.09% over the month.
Analysts are in expectations that BioPlus Acquisition Corp. (BIOS) stock would likely to be making an EPS of -$0.09 in the current quarter, while forecast for next quarter EPS is -$0.06 and it is $0.32 for next year. For the current quarter EPS, analysts have given the company a lowest target -$0.14 which is -$0.04 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$0.4 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 63.30% while it is estimated to increase by 277.80% in next year. EPS is likely to grow at an annualized rate of 10.00% for next 5-years, compared to annual growth of -9.93% made by the stock over the past 5-years.
Analysts at 0 brokerage firms have issued recommendations for the BioPlus Acquisition Corp. (BIOS)’s stock and average of those rates the stock at a “Strong Buy” and assign it a score of 1.40. Out of those 0 Wall Street analysts, 0 recommended a “Buy” rating, while 0 were in favor recommending the stock as a “Hold” and 0 analyst recommended the stock as “Sell”.
